Report Detail
Global Granulocyte Macrophage Colony Stimulating Factor Market Insights, Forecast to 2025
- RnM2910582 |
- 08 February, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
The global Granulocyte Macrophage Colony Stimulating Factor market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Granulocyte Macrophage Colony Stimulating Factor market based on company, product type, end user and key regions.
This report studies the global market size of Granulocyte Macrophage Colony Stimulating Factor in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Granulocyte Macrophage Colony Stimulating Factor in these regions.
This research report categorizes the global Granulocyte Macrophage Colony Stimulating Factor market by top players/brands, region, type and end user. This report also studies the global Granulocyte Macrophage Colony Stimulating Factor market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Aduro BioTech Inc
Amgen Inc
BriaCell Therapeutics Corp
Cold Genesys Inc
GlaxoSmithKline Plc
Humanigen Inc
Mologen AG
Morphotek Inc
Sillajen Biotherapeutics
Takeda Pharmaceutical Co Ltd
Market size by Product
CG-0070
Gimsilumab
GSK-3196165
Lenzilumab
MGN-1601
Others
Market size by End User
Solid Tumor
Lymphoma
Kidney Cancer
Lung Disease
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Granulocyte Macrophage Colony Stimulating Factor market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Granulocyte Macrophage Colony Stimulating Factor market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Granulocyte Macrophage Colony Stimulating Factor companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Granulocyte Macrophage Colony Stimulating Factor submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Granulocyte Macrophage Colony Stimulating Factor are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Granulocyte Macrophage Colony Stimulating Factor market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Granulocyte Macrophage Colony Stimulating Factor Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate by Product
- 1.4.2 CG-0070
- 1.4.3 Gimsilumab
- 1.4.4 GSK-3196165
- 1.4.5 Lenzilumab
- 1.4.6 MGN-1601
- 1.4.7 Others
- 1.5 Market by End User
- 1.5.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate by End User
- 1.5.2 Solid Tumor
- 1.5.3 Lymphoma
- 1.5.4 Kidney Cancer
- 1.5.5 Lung Disease
- 1.5.6 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size
- 2.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Revenue 2014-2025
- 2.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales 2014-2025
- 2.2 Granulocyte Macrophage Colony Stimulating Factor Growth Rate by Regions
- 2.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales by Regions
- 2.2.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Granulocyte Macrophage Colony Stimulating Factor Sales by Manufacturers
- 3.1.1 Granulocyte Macrophage Colony Stimulating Factor Sales by Manufacturers
- 3.1.2 Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Manufacturers
- 3.1.3 Global Granulocyte Macrophage Colony Stimulating Factor Market Concentration Ratio (CR5 and HHI)
- 3.2 Granulocyte Macrophage Colony Stimulating Factor Revenue by Manufacturers
- 3.2.1 Granulocyte Macrophage Colony Stimulating Factor Revenue by Manufacturers (2014-2019)
- 3.2.2 Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Manufacturers (2014-2019)
- 3.3 Granulocyte Macrophage Colony Stimulating Factor Price by Manufacturers
- 3.4 Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base Distribution, Product Types
- 3.4.1 Granulocyte Macrophage Colony Stimulating Factor Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Granulocyte Macrophage Colony Stimulating Factor Product Type
- 3.4.3 Date of International Manufacturers Enter into Granulocyte Macrophage Colony Stimulating Factor Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales by Product
- 4.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Product
- 4.3 Granulocyte Macrophage Colony Stimulating Factor Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Granulocyte Macrophage Colony Stimulating Factor Breakdown Data by End User
6 North America
- 6.1 North America Granulocyte Macrophage Colony Stimulating Factor by Countries
- 6.1.1 North America Granulocyte Macrophage Colony Stimulating Factor Sales by Countries
- 6.1.2 North America Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Granulocyte Macrophage Colony Stimulating Factor by Product
- 6.3 North America Granulocyte Macrophage Colony Stimulating Factor by End User
7 Europe
- 7.1 Europe Granulocyte Macrophage Colony Stimulating Factor by Countries
- 7.1.1 Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Countries
- 7.1.2 Europe Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Granulocyte Macrophage Colony Stimulating Factor by Product
- 7.3 Europe Granulocyte Macrophage Colony Stimulating Factor by End User
8 Asia Pacific
- 8.1 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor by Countries
- 8.1.1 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Countries
- 8.1.2 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor by Product
- 8.3 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor by End User
9 Central & South America
- 9.1 Central & South America Granulocyte Macrophage Colony Stimulating Factor by Countries
- 9.1.1 Central & South America Granulocyte Macrophage Colony Stimulating Factor Sales by Countries
- 9.1.2 Central & South America Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Granulocyte Macrophage Colony Stimulating Factor by Product
- 9.3 Central & South America Granulocyte Macrophage Colony Stimulating Factor by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor by Countries
- 10.1.1 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Countries
- 10.1.2 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor by Product
- 10.3 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor by End User
11 Company Profiles
- 11.1 Aduro BioTech Inc
- 11.1.1 Aduro BioTech Inc Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Products Offered
- 11.1.5 Aduro BioTech Inc Recent Development
- 11.2 Amgen Inc
- 11.2.1 Amgen Inc Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Products Offered
- 11.2.5 Amgen Inc Recent Development
- 11.3 BriaCell Therapeutics Corp
- 11.3.1 BriaCell Therapeutics Corp Company Details
- 11.3.2 Company Business Overview
- 11.3.3 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Products Offered
- 11.3.5 BriaCell Therapeutics Corp Recent Development
- 11.4 Cold Genesys Inc
- 11.4.1 Cold Genesys Inc Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Products Offered
- 11.4.5 Cold Genesys Inc Recent Development
- 11.5 GlaxoSmithKline Plc
- 11.5.1 GlaxoSmithKline Plc Company Details
- 11.5.2 Company Business Overview
- 11.5.3 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Products Offered
- 11.5.5 GlaxoSmithKline Plc Recent Development
- 11.6 Humanigen Inc
- 11.6.1 Humanigen Inc Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Products Offered
- 11.6.5 Humanigen Inc Recent Development
- 11.7 Mologen AG
- 11.7.1 Mologen AG Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Products Offered
- 11.7.5 Mologen AG Recent Development
- 11.8 Morphotek Inc
- 11.8.1 Morphotek Inc Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Products Offered
- 11.8.5 Morphotek Inc Recent Development
- 11.9 Sillajen Biotherapeutics
- 11.9.1 Sillajen Biotherapeutics Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Products Offered
- 11.9.5 Sillajen Biotherapeutics Recent Development
- 11.10 Takeda Pharmaceutical Co Ltd
- 11.10.1 Takeda Pharmaceutical Co Ltd Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Products Offered
- 11.10.5 Takeda Pharmaceutical Co Ltd Recent Development
12 Future Forecast
- 12.1 Granulocyte Macrophage Colony Stimulating Factor Market Forecast by Regions
- 12.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Regions 2019-2025
- 12.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Regions 2019-2025
- 12.2 Granulocyte Macrophage Colony Stimulating Factor Market Forecast by Product
- 12.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Product 2019-2025
- 12.2.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Product 2019-2025
- 12.3 Granulocyte Macrophage Colony Stimulating Factor Market Forecast by End User
- 12.4 North America Granulocyte Macrophage Colony Stimulating Factor Forecast
- 12.5 Europe Granulocyte Macrophage Colony Stimulating Factor Forecast
- 12.6 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Forecast
- 12.7 Central & South America Granulocyte Macrophage Colony Stimulating Factor Forecast
- 12.8 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Granulocyte Macrophage Colony Stimulating Factor Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Granulocyte Macrophage Colony Stimulating Factor . Industry analysis & Market Report on Granulocyte Macrophage Colony Stimulating Factor is a syndicated market report, published as Global Granulocyte Macrophage Colony Stimulating Factor Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Granulocyte Macrophage Colony Stimulating Factor market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
